Results 151 to 160 of about 18,010 (199)

Colistin, Meropenem-Vaborbactam, Imipenem-Relebactam, and Eravacycline Testing in Carbapenem-Resistant Gram-Negative Rods: A Comparative Evaluation of Broth Microdilution, Gradient Test, and VITEK 2. [PDF]

Antibiotics (Basel)
Forstner P, Fuchs L, Luxner J, Grisold A, Steinmetz I, Dichtl K.   +5 more
europepmc   +1 more source

First case report of a vertebral osteomyelitis caused by carbapenem-resistant Enterobacter cloacae treated with imipenem/cilastatin/relebactam prolonged infusion then meropenem/vaborbactam in continuous infusion. [PDF]

Front Pharmacol
Laffont-Lozes P, Naciri T, Pantel A, Martin A, Pruvot-Occean AS, Haignere V, Loubet P, Sotto A, Larcher R.   +8 more
europepmc   +1 more source

Meropenem-Vaborbactam for the Treatment of Post-Neurosurgical Meningitis Caused by KPC Producer Klebsiella Pneumoniae: A Case Report and Review of the Literature. [PDF]

Antibiotics (Basel)
Rezzonico LF, Peracchi F, Vecchi M, Bassi G, Merli M, Bana NB, Travi G, Crippa F, Puoti M.   +8 more
europepmc   +1 more source

Whole-genome sequencing characterisation of a new KPC-245 variant-carrying Klebsiella pneumoniae strain isolated from a transplanted patient and resistant to ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam

Claudia Vaiana, Roberta Vazzana, Salvatore Castelbuono, Andrea Cona, Alessandra Mularoni, Rita Minucci, Francesco Monaco, Daniele Di Carlo, Pier Giulio Conaldi, Alessia Gallo, Nicola Cuscino   +10 more
openalex   +1 more source

In vitro Synergistic and Bactericidal Effects of Aztreonam in Combination with Ceftazidime/ Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam Against Dual-Carbapenemase-Producing Enterobacterales. [PDF]

Infect Drug Resist
Fu Y, Zhu Y, Zhao F, Yao B, Yu Y, Zhang J, Chen Q.   +6 more
europepmc   +1 more source

Systematic Review and Meta-Analysis of Clinical Efficacy and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections. [PDF]

Int J Mol Sci
Bucataru A, Turcu-Stiolica A, Calina D, Balasoiu AT, Zlatian OM, Osman A, Balasoiu M, Ghenea AE.   +7 more
europepmc   +1 more source

In vitro activity of ceftazidime/avibactam, cefiderocol, meropenem/vaborbactam and imipenem/relebactam against clinical strains of the Stenotrophomonas maltophilia complex. [PDF]

PLoS One
Méndez-Sotelo BJ, Delgado-Beltrán M, Hernández-Durán M, Colín-Castro CA, Esquivel-Bautista J, Ortega-Oliva SA, Ortiz-Álvarez J, García-Contreras R, Franco-Cendejas R, Lopez Jacome LE.   +9 more
europepmc   +1 more source

Comparative In Vitro Activity of Ceftazidime-Avibactam, Imipenem-Relebactam, and Meropenem-Vaborbactam against Carbapenem-Resistant Clinical Isolates of Klebsiella pneumoniae and Pseudomonas aeruginosa. [PDF]

Antibiotics (Basel)
Sophonsri A, Kalu M, Wong-Beringer A.
europepmc   +1 more source

Corrigendum to “Simultaneous post-neurosurgical ventriculitis and bacteraemia by two different strains of KPC-producing K. pneumoniae successfully treated with meropenem/vaborbactam and high dose of Fosfomycin” [Journal of Global Antimicrobial Resistance 37 (2024) 86-90]

Lorenzo Volpicelli, Sara Cairoli, Dania Al Ismail, F Baisi, Federica Sacco, Bianca Maria Goffredo, Mario Venditti, Alessandra Oliva   +7 more
openalex   +1 more source